Stock ACTC ADVANCED CELL TECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Advanced Cell Technology, Inc. OTC Bulletin Board

Equities

ACTC

US00752K1051

Biotechnology & Medical Research

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Advanced Cell Technology, Inc.

Managers

Managers TitleAgeSince
Yoshitsuga Shitaka PSD
 President - -
John Heffernan PRN
 Corporate Officer/Principal - 15-02-02

Members of the board

Members of the board TitleAgeSince
Percival Barretto-Ko BRD
 Director/Board Member 51 -
Masaaki Hirano BRD
 Director/Board Member 57 -
Toru Yoshimitsu BRD
 Director/Board Member 61 -
Yoshitsuga Shitaka PSD
 President - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 42,300,462 38,904,811 ( 91.97 %) 0 91.97 %

Company contact information

Astellas Institute for Regenerative Medicine

33 Locke Drive

01752, Marlborough

+508-756-1212

https://www.ocata.com
address Advanced Cell Technology, Inc.(ACTC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.51% 104B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+3.22% 97.42B
ARGENX SE Stock argenx SE
+1.11% 22.2B
BIONTECH SE Stock BioNTech SE
-16.53% 21.23B
GENMAB A/S Stock Genmab A/S
-8.52% 18.33B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.33% 16.35B
BEIGENE, LTD. Stock BeiGene, Ltd.
-20.09% 15.06B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.47% 13.98B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+28.85% 11.66B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock
  4. ACTC Stock
  5. Company Advanced Cell Technology, Inc.